Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Dr Arthur Levinson joins board at NGM

This article was originally published in Scrip

Executive Summary

NGM Biopharmaceuticals, a private US company discovering and developing biotherapeutics for the treatment of type 2 diabetes and other metabolic diseases, has elected Dr Arthur Levinson to its board of directors. Dr Levinson is chairman of Genentech's board of directors, an advisor to Genentech's research and early development centre and a member of Roche's scientific resource board. He will also be nominated to Roche's board of directors in March 2010.


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts